scholarly journals Angiosarcoma of an Arteriovenous Fistula for Hemodialysis in a Kidney Transplant Recipient Affected by Lowe’s Syndrome

2020 ◽  
Vol 2020 ◽  
pp. 1-4
Author(s):  
V. D’Ambrosio ◽  
P. Silvestri ◽  
F. Aureli ◽  
A. Sturniolo ◽  
G. Grandaliano ◽  
...  

Objective/Background. To describe an uncommon, life-threatening condition such as angiosarcoma of a fistula for hemodialysis occurring in a transplant recipient affected by Lowe’s syndrome. Summary. We present the case of a 56-year-old male kidney transplant recipient affected by Lowe’s syndrome, also known as oculocerebrorenal syndrome, a rare X-linked disorder characterized by congenital cataracts, hypotonia, intellectual disability, and Fanconi-like renal tubular dysfunction, who was diagnosed with angiosarcoma of a functioning arteriovenous fistula for hemodialysis. Conclusion. Angiosarcoma is a rare soft tissue tumor, and only 22 cases of angiosarcoma of arteriovenous fistulae were described so far; although a correlation between Lowe’s syndrome and a higher risk of tumor compared to the general population has not been described so far, the mechanisms of disease causation could be an interesting starting point for future studies on a possible connection between the two events.

2021 ◽  
Vol 12 ◽  
Author(s):  
Liru Qiu ◽  
Ji Zhang ◽  
Yafei Huang ◽  
Gen Chen ◽  
Zhishui Chen ◽  
...  

The long-term impact of COVID-19 on transplant recipients remains unknown. We describe the case of a 30-year-old male kidney transplant recipient from Wuhan, China that was treated for severe COVID-19 in February 2020. He suffered an acute lung and renal injury and required systemic treatment including adjustment of his immunosuppressant regime. He was followed up to 1-year after discharge. No chronic lung fibrosis or deterioration of his pulmonary function was observed. Despite COVID-19 mediated damage to his renal tubular cells, no transplant rejection occurred. His immunological profile demonstrated both cellular anti-SARS-CoV-2 reactivity and specific humoral immunity, indicating that it is beneficial for the transplanted patients to be immunized with SARS-CoV-2 virus vaccine. This case will help guide clinical decision making for immunocompromised individuals that become infected with SARS-CoV-2.


2017 ◽  
Vol 7 (1) ◽  
pp. 5-8
Author(s):  
Akihiro Ryuge ◽  
Masahiko Yazawa ◽  
Kazuki Kitajima ◽  
Ryuto Nakazawa ◽  
Hideo Sasaki ◽  
...  

Author(s):  
Riyadh A. Aldaabil ◽  
Ahmed M. Alkhunaizi ◽  
Najla A. Al-Dawsari ◽  
Mohamad F. Dawamneh ◽  
Rola Rabah

2020 ◽  
Vol 21 (1) ◽  
pp. 428-430
Author(s):  
Jin Sasaki ◽  
Satoru Shinkuma ◽  
Riichiro Abe

Sign in / Sign up

Export Citation Format

Share Document